RS67506 free base
RS67506 free base is a 5-HT4 receptor partial agonist. RS67506 free base activates Gs-coupled signaling, increases cAMP/PKA and CREB phosphorylation/nuclear translocation, and promotes enteric neuron survival, neurogenesis, and GFAP -positive glial cell proliferation. RS67506 free base can be used for research on enteric neuropathy and constipation.
For research use only. We do not sell to patients.
- CAS No.: 160845-97-6
- Formula: C18H28ClN3O4S
- Molecular Weight:417.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All 5-HT Receptor Isoforms
More
Biological Activity
Description
|
5-HT4 Receptor |
PKA |
cAMP |
CREB |
In Vitro
RS67506 (0.1-10 nM; 20 min) free base increases CREB phosphorylation and nuclear pCREB in adult mouse enteric neurons through 5-HT4 and PKA-sensitive signaling pathways[1].
RS67506 (60 min) free base is a high-affinity 5-HT4 ligand (pKi 8.8) in guinea pig striatal membranes, with significant σ1/σ2 binding (pKi 7.9/7.3) and lower affinity for other tested receptors[4].
RS67506 free base is a potent partial 5-HT4 receptor agonist in the rat isolated esophageal muscularis mucosae (pEC50 8.8; 0.6 relative to 5-HT)[4].
RS67506 (30 min) free base is a partial agonist of the 5-HT4 receptor in the rat esophageal muscularis mucosae, with a pEC50 of 7.5 and an intrinsic activity of 0.6 relative to 5-HT[7].
RS67506 free base binds to guinea pig striatal 5-HT4 receptors with a pKi of 8.8 and to NG108-15 cell 5-HT3 receptors with a pKi of 5.6[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:β3-tubulin-positive neuronal
-
Concentration:0.1; 1; 10; 100 nM
-
Incubation Time:48 h
-
Result:Promoted neuronal development/survival and neurite outgrowth in a concentration-dependent manner.
This effect was blocked by GR 113808 (HY-103152).
-
Cell Line:Adult mouse enteric neurons
-
Concentration:0.1; 10 nM
-
Incubation Time:20 min
-
Result:Increased CREB phosphorylation and intranuclear pCREB.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:SvEv129 (male, at least 6 weeks old)[1]
-
Dosage:11.4 fmol/d (intraperitoneal osmotic pump); 100 nM (drinking water)
-
Administration:intraperitoneal continuous osmotic pump infusion for 7 days; oral drinking water during post-BrdU chase
-
Result:Continuous BrdU produced BrdU-labeled extraganglionic cells with punctate HuC/D immunoreactivity in WT small and large intestine after 2-4 weeks of chase.
Virtually no BrdU/HuC/D coexpression was seen.
After 4 weeks, BrdU-labeled cells coexpressed DCX, Sox10, Phox2b, or nestin, and a subset coexpressed Musashi-1.
Rare cells showed perinuclear HuC/D.
HuC/D/BrdU cells were extraganglionic at 4 weeks and closely apposed to myenteric ganglia by 16 weeks.
In-cell ELISA showed increased BrdU incorporation in WT LMMP after 4 weeks relative to vehicle.
-
Animal Model:Yucatan micropig (male and female; 17-22 kg)[4]
-
Dosage:0.3-300 μg/kg
-
Administration:i.v. bolus; ascending series; 10 minutes between doses
-
Result:Produced dose-dependent increases in heart rate.
ED50 was 5.4 μg/kg i.v.
The maximum heart rate increase was 47 beats/min.
-
Animal Model:Wistar Hannover GALAS (male, 200-250 g)[5]
-
Dosage:5 μmol in 200 μL saline
-
Administration:intraluminal into the proximal colon via the manometric catheter; single administration
-
Result:Intraluminal administration increased the frequency of phase III-like contractions and %MI in both the proximal and distal colon and increased the number of excreted fecal pellets.
In the distal colon, i.v. wood creosote 5 μg prevented the increases in phase III-like contraction frequency and %MI; in the proximal colon, the increases were not altered.
I.v. wood creosote 5 μg also prevented the increase in fecal pellet output.
- Western Blot
- BrdU Incorporation Assay
- Somatic Cell Culture
- CFSE Dye Dilution Proliferation Assay
- Dye-dilution cell tracking and proliferation staining
- Cell differentiation
- CCK-8/WST-8 Cell Proliferation Assay
- Protocol for Cell Cycle
- Cell Counting-Based Growth Curve Assay
- Colony Formation (Clonogenic) Assay
- Cell Viability Determination by MTT Colorimetric Assay
- Kinase activity and phosphorylation assays
- Cytoplasmic-Nuclear Fractionated Protein Extraction
- EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
- Ki-67 Immunostaining Proliferation Assay
- PCNA Immunodetection Proliferation Assay
- Protocol for Cell Counting and Cell Density Analysis
- SH-SY5Y neuronal-like differentiation
- Protocol for Kinase activity and phosphorylation assays
- MTT Cell Proliferation Assay
Chemical Information
-
CAS No. 160845-97-6
-
Molecular Weight 417.95
-
Formula C18H28ClN3O4S
-
SMILES
O=C(CCC1CCN(CC1)CCNS(=O)(C)=O)C2=CC(Cl)=C(C=C2OC)N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- RS67506
- 160845-97-6
- RS 67506
- RS-67506
- 5-HT Receptor
- PKA
- Serotonin Receptor
- 5-hydroxytryptamine Receptor
- Protein kinase A
- 5-HT4 receptor
- CREB phosphorylation
- cAMP/PKA signaling
- constipation
- enteric nervous system
- enteric neurogenesis
- enteric neuropathies
- neural stem cells
- neurite outgrowth
- partial agonist
- Inhibitor
- inhibitor
- inhibit